TriNet (TNET) Stock: Why Curreen Capital Calls This HR Services Turnaround ‘Crazy-Cheap’ in 2026

Trinet

TriNet (TNET) Emerges as a ‘Crazy-Cheap’ Turnaround Play in Q2 2026

Investment management firm Curreen Capital has identified TriNet Group, Inc. (NYSE: TNET) as one of its top turnaround opportunities in its second-quarter 2026 investor letter. The fund added to its position, calling the human capital management company ‘crazy-cheap’ following a difficult stretch driven by volatile healthcare costs.

On August 10, 2026, TriNet closed at $67.35 per share, giving the company a market capitalization of $3.09 billion. The stock posted a one-month return of 18.49%, a year-to-date gain of 13.90%, and a 52-week return of 4.47%.

Curreen Capital’s Q2 2026 Performance

Curreen Capital delivered a 22.26% return in the second quarter of 2026, outpacing the S&P 500 Index, which returned 15.20% over the same period. The outperformance was driven by active special situation investments, including tender offers, merger-spinoffs, and what the firm describes as ‘affordable turnaround opportunities’ like TriNet.

Why TriNet Looks Undervalued

TriNet is a professional employer organization (PEO) that provides health insurance, payroll, and retirement account services to small and mid-sized businesses. According to Curreen Capital, the company went through a turbulent period as healthcare costs first dropped during the COVID-19 pandemic and then surged rapidly, making it difficult to forecast expenses and properly price insurance offerings to clients.

The result: TriNet was forced to raise prices significantly, which cost it customers in both 2025 and 2026. However, Curreen believes the worst is over. The company now has better visibility into its pricing and cost structure, and profit margins are rebounding toward longer-term averages. Operating results have likely bottomed, setting up a multi-year recovery story that should drive the stock price higher from what the fund calls ‘crazy cheap’ levels.

Hedge Fund Sentiment on TNET

According to Insider Monkey’s database, 25 hedge fund portfolios held TriNet at the end of the first quarter, down from 33 in the previous quarter. While the declining institutional interest may concern some investors, Curreen sees the under-the-radar positioning as an opportunity for those willing to look past short-term turbulence.

Key Takeaways for Investors

  • Valuation: $3.09 billion market cap with potential margin recovery ahead.
  • Catalyst: Stabilization in healthcare cost forecasting and pricing accuracy.
  • Risk: Continued customer churn if pricing actions take longer to absorb.
  • Thesis: A high-quality business trading at a discount due to a manageable operational setback.

For income-oriented investors, note that TriNet is not currently featured on the list of the 40 Most Popular Stocks Among Hedge Funds Heading Into 2026, suggesting room for institutional accumulation if the turnaround thesis plays out.

Frequently Asked Questions (FAQ)

What does TriNet Group (TNET) do?

TriNet Group is a professional employer organization (PEO) that provides human capital management services—including health insurance, payroll processing, retirement plan administration, and HR compliance—to small and medium-sized businesses across the United States.

Why did Curreen Capital call TriNet ‘crazy cheap’?

Curreen Capital believes TriNet’s stock price does not reflect the company’s long-term earnings power. After a difficult period caused by unpredictable healthcare costs during the COVID-19 era, the firm argues that profit margins are rebounding and the operating turnaround is already underway, creating an attractive risk-reward setup at current levels.

What are the main risks of investing in TNET stock?

The primary risks include further customer attrition if TriNet’s pricing adjustments take longer to stabilize, continued volatility in healthcare claim costs, and broader macroeconomic headwinds affecting the small and mid-sized business customer base. A 52-week return of just 4.47% suggests the market is still uncertain about the recovery pace.

Leave a Comment